ERYTECH Pharma
ERYTECH Pharma Receives (EURO) 7 Million from OSEO to Lead the TEDAC Personalized Medicine Project in Cancer
Published in Pharma Business Week, June 18th, 2012
2012 JUN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- ERYTECH Pharma, a late-stage French biopharmaceutical company developing medicinal products for oncology, is pleased to announce that it received a total of € 6.95 million in support from the Strategic Industrial Innovation program of the French public organization OSEO to lead the TEDAC project (Therapeutic Enzymes to Deplete Amino acids to treat Cancers resistant to radio/chemotherapy).
The consortium also includes Exonhit, InGen BioSciences, AP-HP (Paris Public Hospitals), Inserm (National Institute for medical research), and Paris-Diderot University. It aims at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
Source: Pharma Business Week (2012-06-18)
More Articles from Pharma Business Week
- Therapeutics
Express Scripts to Present at William Blair Growth Stock Conference - Pharmaceutical Companies
Michael Hercz Joins Deloitte's Governance, Regulatory & Risk Strategies Practice - Biopharmaceuticals
PHT Corporation Founder Dr. Stephen Raymond and Europe GM Valdo Arnera, MD Address the Impact of eClinical Technology Innovation on Biopharmaceuticals, CROs and Patients at DIA 2012 - Best Practices, Llc
Pharmaceutical Industry Relies on Medical Science Liaisons to Generate Value Across Diverse Customer Groups - Pharmacokinetics
Pharmacogenetics and Individualized Therapy - Revitas
UCB, Inc. Adopts Revitas Product Suite to Optimize Enterprise Revenue Dynamics - More from this issue of Pharma Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
